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Summary
Synthetic Biology is in a critical phase of its develop-
ment: it has finally reached the point where it can
move from proof-of-principle studies to real-world
applications. Secondary metabolite biosynthesis,
especially the discovery and production of antibio-
tics, is a particularly relevant target area for such
applications of synthetic biology. The first interna-
tional conference to explore this subject was held in
Spain in October 2011. In four sessions on General
Synthetic Biology, Filamentous Fungal Systems, Acti-
nomyces Systems, and Tools and Host Structures,
scientists presented the most recent technological
and scientific advances, and a final-day Forward Look
Plenary Discussion identified future trends in the
field.
Introduction
Synthetic biology is considered as the major future trend
for biotechnology: our newly increased ability to sequence
and (most importantly) synthesize entire genomes
enables a new engineering-style approach to manipulat-
ing biological systems (Leonard et al., 2008; Khalil and
Collins, 2010; Tyo et al., 2010; Tsvetanova et al., 2011). At
the moment, much of the potential of Synthetic Biology is
realized only at the level of proof-of-principle studies and
general plans, but some areas of microbiology are already
geared up for applied synthetic biology. The field of sec-
ondary metabolism, especially the discovery and produc-
tion of bioactive compounds, including antibiotics, is
particularly well positioned for such a strategy. Biosyn-
thetic pathways for secondary metabolites are modular at
multiple levels, and therefore are a natural target for
re-engineering and the synthetic creation of additional
chemical diversity (Carothers et al., 2009; Fischbach and
Voigt, 2010; Gao et al., 2010; Dhamankar and Prather,
2011; Medema et al., 2011a,b; 2012).
On 2–7 October 2011, more than 100 synthetic biolo-
gists and fungal/actinomycete natural products biologists
met at the Hotel Eden Roc, Sant Feliu de Guíxols (Costa
Brava), Spain, to explore the state of the art and future
directions of the field in a meeting co-hosted by the
European Science Foundation (ESF) and the European
Molecular Biology Organization (EMBO). A perfect venue
overlooking the rocky cliffs of the Mediterranean Sea and
the beautiful late-summer weather provided the ideal
environment to bring together these two very different
communities to exchange ideas and to form new
collaborations. The aim was more than achieved, with
talks and posters from established group leaders, as well
as the young scientists who will lead the future of Syn-
thetic Biology. Many talks included unpublished and hot-
off-the-bench data and inspired all participants to lively
discussions. Forty-seven posters were presented, and
each poster author gave a 1 min talk on their work
(without slides). This was a widely approved highlight of
the whole conference, which led to many enthusiastic
interactions during the subsequent poster sessions.
Three prizes were awarded to young researchers: the
SGM young speaker prize was awarded to Daniel Scharf,
PhD student, Leibniz Institute for Natural Product
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Research and Infection Biology e.V., Jena, Germany,
for his talk entitled: Gliotoxin pathway reconstruction
as a prerequisite for pathway engineering. The Nature
Reviews Microbiology poster prize was awarded by
Andrew Jermy (NRM senior editor) to Eva-Maria Niehaus,
PhD student, Westfälische Wilhelms-Universität Münster,
Germany, for her poster with the title: Molecular and
chemical characterization of secondary metabolite gene
clusters in Fusarium fujikuro: the fusarin gene cluster. The
EMBO Reports poster prize was awarded to Tina Strobel,
PhD student, Albert-Ludwigs-University, Freiburg im Bre-
isgau, Germany, for her poster with the title: Identification
of a highly flexible glycosyltransferase from Saccharothrix
espanaensis.
Another important feature of the conference was the
active participation from industry. Eighteen industrial
researchers attended the conference, with six presenting
short talks or posters, reflecting a (re-)growing interest in
natural products in the light of the recent advances of
synthetic biology approaches in the field.
The meeting was an excellent illustration of how far we
have proceeded in the last couple of years, both in our
understanding of secondary metabolite biosynthesis and
in our tools for large-scale genetic manipulation. At the
same time as bringing together synthetic biology and
natural products, and inspiring collaborations within the
natural products community, it also identified important
bottlenecks in the current synthetic biology pipeline and
important limitations of our biological understanding of the
relevant biosynthetic pathways and their regulation, which




The conference was opened by Roy Kishony (Harvard
University, USA) with his inspiring presentation of new data
on ‘The ecology of antibiotics’, using experimental and
computational modelling strategies to explain the natural
evolution of antibiotics resistance, answering the intriguing
question, why haven’t all bacteria become resistant yet?
The complex spatial and temporal dynamics of antibiotics
gradients lead to significant growth advantages of
antibiotic-sensitive strains even in the presence of antibi-
otics producers. Roy also presented his very recent work
on Streptomyces inter-species interactions (Vetsigian
et al., 2011). Sixty-four Streptomyces strains were isolated
from soil and observed for sender–receiver interactions
using antibiotic production, resistance and growth. The
results show that the interactions evolve quickly, and math-
ematical modelling of the ecological dynamics of antibiotic
production and resistance suggested that in a diverse
Streptomyces community the interaction network is evolu-
tionarily dynamic. Therefore the antibiotics produced by
Streptomyces are forever diverse. This was good news to
those of the audience looking for novel antibiotics!
Christina Smolke (Stanford, USA) presented a large
collection of tools for the control of gene expression in
yeast, mostly based on RNA and its secondary structure,
and showed how to use these switches to control antibi-
otic production. She illustrated this, for example, by RNA-
based control modules to control translation using the
RNase Rnt1p, which cleaves the conserved sequence in
an RNA hairpin (Fig. 1) (Babiskin and Smolke, 2011a).
Based on these data Christina argued that the flexibility
of RNA molecules as sensors, computing devices and
actuators, and their compatibility with the existing endog-
enous regulatory machinery, makes them particularly
promising as portable programmable tools for the design
and engineering of tightly controlled metabolic pathways.
Markus Schmidt (Biofaction and IDC, Austria) dis-
cussed ‘Biosafety and Public Dialogue in Synthetic
Biology’, raising awareness of an important but often
neglected issue by showing examples of public engage-
ment through animation, films and art. Although synthetic
biology of antibiotics itself is usually not perceived as a
threat to society, this is still an important issue, given the
generally cautious attitude of the public towards large-
scale genetic engineering. To illustrate the pro-active
approach taken by researchers in the field, Markus showed
an animation created by the consortium SYNMOD in Euro-
SYNBIO (ESF funded) to raise awareness concerning the
importance of our search for novel antibiotics that can
combat antibiotic-resistant pathogens. At the Bio:fiction
Science Art and Film Festival held in Vienna in May 2011,
over 52 short films related to synthetic biology were shown
ranging from documentary films to animations and pure
science fiction (http://www.bio-fiction.com). Artists also
presented 10 pieces of art related to synthetic biology at
the art-science exhibition ‘synth-ethic’, produced by
Markus and curated by Jens Hauser, in the Museum of
Natural History in Vienna, May to June 2011, demonstrat-
ing an extremely diverse interpretation of synthetic biology
by international artists (http://www.biofaction.com/synth-
ethic/).
Arnold Driessen (University of Groningen, The Neth-
erlands) reported data on the engineering of Penicillium
chrysogenum for the overproduction of penicillin. There
are about 830 transporters encoded in the genome of
P. chrysogenum, including 49 ABC transporters. From
these ABC transporters, 23 were selected based on their
expression profile in penicillin-producing conditions and
deleted. One showed a lowered production of penicillin
and may represent a potential bottleneck transport reac-
tions during penicillin biosynthesis. It is now the target of
overexpression studies (Weber et al., 2011).
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Jörg Stelling (ETH, Switzerland) provided a systems
biologist’s perspective on synthetic biology, discussing to
which extent can we come up with a biological design that
really works, in the face of lack of knowledge, system
sloppiness, stochasticity and limited insulation, by exploit-
ing general design principles. Jörg argued that to provide
synthetic biology with the reliable, predictable behaviour
that characterized classical engineering, it will be neces-
sary to complement the molecular standard parts [‘bio-
bricks’ (Shetty et al., 2008)] with similarly standardized
mathematical models. The potential of a quantitative engi-
neering approach was evidenced by the development of
computational tools to automatically and rationally design
a genetic circuit with predictable regulatory properties
(Fig. 2) (Marchisio and Stelling, 2011).
Several short talks in this session presented new assem-
bly methods for large DNA fragments. Nili Ostrov from
Virginia Cornish’s laboratory (Columbia University, USA)
gave an overview of the reiterative recombination technol-
ogy for assembly of an in principle unlimited number of
DNA fragments into the chromosome of Saccharomyces
cerevisiae (Wingler and Cornish, 2011), which enables
construction of multi-gene biosynthetic pathways and large
combinatorial libraries in a user-friendly manner and using
a minimal number of selective markers. Todd Peterson
(Life Technologies, USA) described the in vivo large-scale
assembly of DNAsequences leveraging the TAR system in
yeast, as well as a low-order, enzymatic in vitro assembly
for vector construction. This topic was further elaborated
by Ralf Wagner (GeneArt/Life Technologies, Germany),
using the example of synthetic lantibiotics. Barry Canton
(Ginkgo Bioworks, USA) presented the logistic and com-
putational challenges of establishing a pipeline for organ-
ism engineering in an industrial context, with the ambitious
aim of automating the steps from initial design to the final
engineered microorganism as far as possible. Another
inspiring talk was from Karsten Temme from Chris Voigt’s
laboratory (UCSF/MIT, USA) who discussed the re-
engineering of a complex biological system, the nitrogen
fixation cluster of Klebsiella oxytoca, by replacing the entire
natural regulatory machinery of this very large and fragile
gene cluster by synthetic elements.
Filamentous Fungal Systems
The second day illuminated a wide range of fungal model
systems for secondary metabolite production. Nancy
Keller (University of Wisconsin, USA) used case studies
from a range of different Aspergillus species to illustrate
the power of developmental biology in unlocking the trea-
sure chest of fungal secondary metabolites, especially
using regulatory genes/elements characterized by her
group. One such method was to mutate proteins involved
in chromatin modification. By mutation of cclA, a gene
involved in a histone-3-lysine-4-methylation, nine second-
ary metabolites were found to be produced (Bok et al.,
2009), and one of them, an emodin derivative, showed
antifungal activity against human pathogenic fungi (Giles
et al., 2011). This method shows the promises of targeted
engineering for awakening the biosynthetic potential of
the huge collection of secondary metabolite biosynthesis
gene clusters identified by genome sequencing.
Axel Brakhage (Leibniz Institute for Natural Product
Research and Infection Biology e.V., Hans-Knöll-Institut,
Fig. 1. Mechanism of the Rnt1p-based post-transcriptional genetic control elements.
A. Consensus structure of the Rnt1p substrate hairpin, indicating the two tuneable modules CEB (red) and BSB (blue), and the initial binding
and positioning box (IBPB) (green). The cleavage sites are indicated by black triangles.
B. Example of a regulatory element implemented using the Rnt1p substrate hairpin in the 30-UTR of a gene of interest (goi) to reduce protein
levels through transcript destabilization by endonucleolytic cleavage. Mutations in the BSB (blue box) and CEB (red box) modules are
expected to tune the hairpin’s affinity for Rnt1p RNase (blue dial) and its sensitivity to cleavage (red dial) respectively.
Figure modified from Babiskin and Smolke (2011b).
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Germany) demonstrated another important strategy for
the activation of silent gene clusters, using the overexpres-
sion of pathway-specific regulatory factors. One of his
examples was the overexpression of a regulator, ScpR,
which awakened the production of the polyketide
asperfuranone although the gene was localized in an
NRPS-encoding gene cluster (cross-pathway regulator)
(Bergmann et al., 2010). Another strategy was to change
the cultivation conditions to mimic those of the host for the
pathogenic fungus Aspergillus fumigatus, e.g. by oxygen
limitation (Vödisch et al., 2011). Using proteome analysis,
117 proteins with altered protein abundance in hypoxic
conditions were identified, including the genes which are
involved in the biosynthesis of pseurotin A, whose biosyn-
thesis genes are silent under normal growth conditions. A
third example of awakening sleeping gene clusters
exploited the co-cultivation of microbes (Streptomyces)
and Aspergillus, which induced the production of orsellinic
acid and its derivatives that are usually not produced in
wild-type fungi. The co-cultured Streptomyces alters the
histone modification of the fungus and thus triggers/
enhances secondary metabolite production (Nützmann
et al., 2011).
Gerhard Braus (University of Göttingen, Germany) illus-
trated the complex regulatory elements in Aspergillus nidu-
lans, and how these regulators are controlled by different
environmental signals and also can effect each other. In
particular, he discussed the often very intricate interplay
between developmental regulators and secondary
metabolite production, as represented by the VelB–VeA–
LaeA protein complex that co-ordinates sexual fruiting
body formation and secondary metabolite production
(Fig. 3) (Sarikaya Bayram et al., 2010; Bayram and Braus,
2012).As another example of a pleiotropic regulator affect-
ing secondary metabolite production and development,
Gerhard introduced the COP9 signalosome (Braus et al.,
2010). Combining data from transcription, protein and
metabolite analysis, the fungal COP9 signalosome was
shown to be required for protection from oxidative stress
and hormone regulation early in development and in later
Fig. 2. Schematic representation of the creation of biological Boolean gates using standardized biological parts. Panels (A) and (B) illustrate
the possible composition of an AND gate (two inputs; A) and a NOR gate (three inputs; B), as well as the corresponding read-out in terms of
the expected protein levels in different input conditions. Inputs can be of different forms, including transcription factors, small RNAs and
chemicals. (Figure modified from Marchisio and Stelling, 2011.)
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development, for the control of secondary metabolite pro-
duction and cell wall arrangement (Nahlik et al., 2010).
In a short presentation in this session, Daniel Scharf
from Axel Brakhage’s laboratory (Leibniz Institute for
Natural Product Research and Infection Biology e.V.,
Hans-Knöll-Institut, Germany) gave his award-winning talk
on the biochemical characterization of the newly charac-
terized enzymes involved in the biosynthesis of the bioac-
tive disulphide motif in gliotoxin, a virulence factor from
A. fumigatus (Scharf et al., 2010; 2011). Stefan Olsson
(University of Copenhagen, Denmark) shared case studies
of discovering new bioactive compounds from fungi by
exploring extreme environments (soil from Greenland
potato fields) and unusual niches (the hyphosphere of
Vietnamese rice plants), and emphasized the importance
of inter-species interactions in the activation of secondary
metabolite production. Vera Meyer (Berlin University of
Technology, Germany) stressed that resistance develop-
ment needs to be considered at an early stage of drug
development and discussed how differences in survival
strategies determine which target organisms will be sensi-
tive or resistant against antibiotics (Ouedraogo et al.,
2011).
Actinomyces Systems
The third day of the meeting was dedicated to exploring
the diversity of actinomycete secondary metabolism. The
scene was, however, set by two talks that focused on
non-actinomycete bacteria with particularly diverse sec-
ondary metabolomes. Jörn Piel (University of Bonn,
Germany), who presented the astonishing chemical rich-
ness of secondary metabolites produced by animal-
associated bacteria, mostly symbionts of marine sponges
(Gurgui and Piel, 2010; Piel, 2011). Metagenomics
revealed pathways for compounds, including psymberin
and the misakinolides, encoded by symbiont gene clus-
ters. Single-cell analysis consisting of cell separation by
flow cytometry, single-cell genome amplification and PCR-
based localization of biosynthetic and 16S rRNA genes
was shown to be a useful method to associate secondary
metabolites with individual producers in complex consortia
of uncultivated bacteria.
Rolf Müller (Helmholtz Institute Pharmaceutical
Research Saarland, Germany) gave a broad-ranging over-
view of the engineering of biosynthetic pathways mostly in
myxobacteria (Weissmann and Müller, 2010), and also
illustrated the power of improved bioanalytical strategies
for identifying novel secondary metabolites by comparative
metabolomics. For example, the identification of products
for previously believed cryptic secondary metabolite path-
ways was demonstrated in Myxococcus xanthus, by a
sophisticated secondary metabolome mining approach
involving comparative high-resolution mass spectrometric
analysis of wild type and PKS/NRPS mutants of the target
strain (Cortina et al., 2012). Novel structures were also
obtained by mutasynthesis. Starting from the elucidated
biosynthetic pathway of cinnabaramides, a class of protea-
Fig. 3. Cartoon of the light-regulated circuitry based on interactions of VelB, VeA and LaeA proteins that integrates morphological
differentiation and secondary metabolism in Aspergillus nidulans. (Figure from Sarikaya Bayram et al., 2010.)
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some inhibitors produced by terrestrial streptomycetes,
one enzyme, CinF, which acts in the reductive carboxyla-
tion of octenoyl-CoA and producing 2-carboxyoctanoyl-
CoA was mutated and chemically synthesized fatty acid
analogues were used to complement the mutant. Grown
in the presence of (E)-6-chlorooct-2-enoic acid (E)-
8-chlorooct-2-enoic acid, and their corresponding N-
acetylcysteamine (NAC) thioesters, new chlorine-
containing compounds were produced, which showed
better inhibitory activity towards all three proteolytic sub-
units of the proteasome (Rachid et al., 2011).
Returning to the evolutionary theme of the first day,
Peter Leadlay (Cambridge University, UK) emphasized
that successful natural products have been shaped and
preserved by natural selection, but that the natural rep-
ertoire represents only a limited sampling of the entire
available chemical space. He then illustrated how syn-
thetic biology approaches, in particular the modular engi-
neering of polyketide synthases, can be used to extend
the range of accessible chemical diversity. For example,
intermediates of the natural biosynthetic pathway could
be accessed in large amounts from a polyketide syn-
thase, 6-deoxyerythronolide B synthase 3, using non-
hydrolysable pantetheine and N-acetyl cysteamine
mimics of the natural (methyl) malonyl extender units
recruited for polyketide formation as competitive sub-
strates (Tosin et al., 2010). The current state of our
biochemical understanding of complex biosynthetic path-
ways was demonstrated by the successful in vitro recon-
stitution of the synthesis of a tetronate polyketide,
3-hexadecanoyl-5-hydroxymethyltetronic acid (Sun et al.,
2010). In vitro synthesis of such a polyketide antibiotic
opens the door to possible recombination/redesigning of
chemical structures.
Wolfgang Wohlleben (University of Tübingen,
Germany) presented unpublished data on redirecting flux
towards balhimycin production, especially by modifica-
tions in primary metabolism, which resulted in overexpres-
sion of biosynthesis pathway enzymes (Thykaer et al.,
2010). Another antibiotic, kirromycin, was also studied for
its unusual trans-AT enzyme, KirCII, which regiospecifi-
cally incorporates the unusual extender unit ethylmalonyl-
CoA (Musiol et al., 2011). These enzymes will be useful
for building diverse module libraries of PKSs.
Diverse synthetic biology approaches were also pre-
sented in the short talks. Anna Eliasson Lantz (Techni-
cal University of Denmark, Denmark) spoke of her recent
work on the construction of a synthetic promoter library
by randomizing the -10 and -35 and the 17 bp spacer
region of the promoter. A library of promoters was
inserted in front of a promoterless activator for actinor-
hodin biosynthesis, actII-ORF4, and visually screened for
actinorhodin production. Interestingly, half of the resulting
isolates did not grow, but from those that did, a collection
of promoters with a wide range of defined strength was
obtained. Justin Nodwell (McMaster University,
Canada) presented unpublished data on his small-
molecule interrogation of the life cycle of Streptomyces
coelicolor. Surprisingly, weak inhibitors of fatty acid syn-
thesis awakened the production of several cryptic antibi-
otics and affected the expression of pleiotropic regulatory
genes. Hiroyasu Onaka (Toyama Prefectural University,
Japan) presented current work on the high-throughput
engineering of NRPS using goadsporin as a proof of
concept (Onaka et al., 2005; Onaka, 2009). Fifty-two
analogues of goadsporin were engineered by deletion
and mutation of the biosynthetic pathway genes. Further
investigation and redesigning is underway to find active
novel compounds.
Tools and Host Structures
On the final day, Luis Serrano (CRG, Spain) started the
session by a systems-biology overview of our current
ability to create a comprehensive quantitative picture of a
microbial systems (specifically Mycoplasma pneumo-
niae), including the quantification of protein and transcript
levels, identification of small RNAs but also of translation
rates, protein half-lives and protein–protein and protein–
DNA interactions, using a combination of technologies,
ranging from next-generation sequencing to electron
microscopy tomography (Fig. 4) (Güell et al., 2011; Maier
et al., 2011). From this analysis, predominantly post-
transcriptional regulation, rather than post-translational
mechanisms, was found to control cellular mRNA-to-
protein abundance ratios, and unusual subunit stoichiom-
etries indicate protein complex dynamics and suggested
possible moonlighting for several ribosomal proteins.
Haruo Ikeda (Kitasato University, Japan) illustrated
how large-scale engineering can improve even estab-
lished hosts for secondary metabolite production,
showing how mega-deletion mutants of the chromosomal
ends can achieve improved industrial potential (Komatsu
et al., 2010). Using this superhost, an epi-isozizaene syn-
thase (SAV 3032) was reintroduced under the promoter
rpsJp (sav4925); while this synthase is normally silent,
under these conditions it produced the previously charac-
terized oxidized epi-isozizaene metabolites (4R)- and
(4S)-albaflavenols and albaflavenone, as well as a novel
doubly oxidized epi-isozizaene derivative, 4b,5b-epoxy-2-
epi-zizaan-6b-ol, which is most likely formed by oxidation
of (4S)-albaflavenol (Takamatsu et al., 2011).
Kristala Jones Prather (MIT, USA) demonstrated the
versatility of new protein devices for biosynthetic pathway
design in an example of increasing the productivity for a
specific small molecule of industrial interest in a heterolo-
gous host, using glucaric acid as an example. A recombi-
nant pathway was engineered to produce the target
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compound in Escherichia coli by placing the required
enzymes from diverse sources onto a synthetic scaffold
held together via eukaryotic protein–protein interaction
domains (Dueber et al., 2009). The flux from glucose to
myo-inositol was redirected towards glucuronic acid by
introducing myo-inositol-1-phosphate synthase from
S. cerevisiae and a mouse myo-inositol oxygenase, and
subsequent introduction of uronate dehydrogenase from
Pseudomonas syringae or Agrobacterium tumefaciens
str. C58 lead to glucaric acid (Moon et al., 2009a,b; 2010).
Michael Fischbach (UCSF, USA) presented a wide-
ranging perspective on the discovery and characterization
of secondary metabolites based on genome sequences
(Fischbach and Voigt, 2010) emphasizing, the broad (and
largely unexplored) phylogenetic distribution of secondary
metabolite biosynthetic gene clusters, many of which
encode for biosynthetic machineries that are larger than a
ribosome and must have immense evolutionary benefits
for their carrier organisms if they show such persistent
evolutionary conservation. Presenting an unpublished
analysis of the global distribution of secondary metabolite
gene clusters in more than 1000 completely sequenced
genomes, he identified underexploited clades with unex-
pectedly rich biosynthetic capacities, and provided new
insights into the pervasive shuffling and recombination of
the biosynthetic machinery across the bacterial kingdom,
which will serve as an important guide in synthetic biolo-
gists’ attempts to further improve on the natural diversity
of compounds.
Beatrix Suess (Frankfurt University, Germany) pre-
sented the engineering of riboswitches which respond to
small molecules, in particular tetracycline and neomycin.
Many aptamers are known to bind to small molecules but
not all have the function to be used as riboswitch. The
Fig. 4. Overview of the large-scale quantitative assessment of mRNA and protein abundance and dynamics in Mycoplasma pneumoniae,
including a summary of the major results. (Figure from Maier et al., 2011.)
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mechanism by which the aptamers can become a
riboswitch was described by using aptamers that respond
to neomycin (Weigand et al., 2011). In addition to high
binding affinity for the ligand (preferably in the nanomolar
range), it is also necessary that the ligand binding induces
a major conformational change, and has the ability to
control the degradation of mRNAs and rRNAs. To engineer
such switches, one tetracycline aptamer was linked to a
hammerhead ribozyme with variable linker sequences.
The resulting hybrid was mutated and selected in vitro for
11 rounds to identify variants that gave tetracycline-
dependent cleavage. Different linker sequences were
determined that were cleaved at 1 mM tetracycline and
were functional in yeast as demonstrated using a GFP
reporter system (Wittmann and Suess, 2011).
Chris Voigt (MIT, USA) challenged the natural product
community to be more daring and ambitious in their adop-
tion of synthetic biology concepts and technologies, illus-
trating the potential of large-scale engineering of biology by
several examples of unpublished data from his group that
had succeeded in completely refactoring complex biologi-
cal systems, ranging from nitrogen fixation (which was also
presented in more detail by Karsten Temme on the first
day) and light harvesting, to protein secretion systems. He
presented the necessary computer-aided design (CAD)
tools, including algorithms to optimize codon usage and
ribosomal binding sites, and versatile promoter and termi-
nator prediction tools (Clancy and Voigt, 2010). He also
presented experimental components for such an enter-
prise, for example light-controlled systems using the phy-
tochrome signalling network of Arabidopsis thaliana (Tabor
et al., 2011), a genetic circuit using quorum sensing
(Tamsir et al., 2011), and a large library of T7 promoters of
different well-characterized promoter strength. However,
he also highlighted the various pitfalls along the way,
stressing that natural products like antibiotics are of ‘nice
intermediate complexity’ to allow a successful application
of synthetic biology, being produced by pathways that are
more complex than most targets of present-day metabolic
engineering, but less daunting than whole-genome design
projects.
In the short talks, Marnix Medema from the Takano
group (University of Groningen, The Netherlands) pre-
sented some of the bioinformatics tools that underlie
the genome-based discovery of secondary metabolites
(Medema et al., 2011c), and Wayne Mitchell (Experimen-
tal Therapeutics Centre, Singapore) placed synthetic
biology in the industrial context, exploring the financial
constraints on natural product discovery and the potential
of synthetic biology and related technologies to overcome
these serious limitations, to provide the necessary
secondary-metabolite-based drugs that are required in
view of the increased resistance observed in many patho-
gens worldwide (Mitchell, 2011).
Forward Look Plenary Discussion
At the end of the conference, participants were asked (i)
to reflect on the take-home message from the meeting, (ii)
to identify challenges and needs of the field, and (iii)
and to predict its medium- to long-term future. The spec-
trum of views was naturally very diverse, but a few impor-
tant common themes emerged.
Concerning the take home message, there were two
recurring views, best reflected in two comments from PhD
students: ‘Synthetic biology is really just starting’ and ‘We
won’t be running out of work any time soon’ – there was
general enthusiasm about the potential of synthetic
biology (‘Synthetic biology ideas will continue to rejuve-
nate natural products research in industrial and academic
groups’), but also a strong realization that it will be chal-
lenging to fully exploit this potential in the rather traditional
field of natural products/antibiotics research (‘Uptake of
synthetic biology approaches by the natural product com-
munity is very limited at present’). The importance of
interdisciplinary conferences bridging the two communi-
ties was widely acknowledged, and participants in general
expressed their excitement about the learning opportuni-
ties offered by bringing together industry, synthetic biolo-
gists and natural products researchers.
A number of important needs and challenges in the field
were repeatedly identified. They included ‘cooperation
and communication between biologist, bioinformatics and
chemists’ (or similar permutations of researchers from
various academic and industrial backgrounds like organic
and analytical chemists), a ‘reduction in the cost of DNA
sequencing and assembly’ and ‘support for interdiscipli-
nary work’. The oral discussion further stressed the need
for interdisciplinary training for a new generation of
students to facilitate such research across traditional
boundaries.
Participants were overall very reluctant to express their
view on the future development of the field, reflecting the
enormous rapidity of progress that makes viable predic-
tions very hard, even on a 5- to 10-year scale. There was,
however, cautious optimism that some major advances
will soon be made to overcome the challenges identified
above: in 5–10 years ‘optimized “general” expression
hosts are available’, ‘there will be synthetic biosynthesis
pathways both for natural and (hopefully) unnatural prod-
ucts’, ‘new natural products will be obtained from heter-
ologously expressed gene clusters’ and, perhaps most
importantly, ‘DNA assembly and synthesis will be cheap
and easy’.
It was clear that we are only at the beginning of a new
era of biotechnology, which will be driven by a renewed
vigour of interdisciplinary interactions. It will be exciting to
see how the new ideas and new collaborations forged at
this meeting will be turned into practical progress towards
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engineering the intricate complexity of antibiotic biosyn-
thesis pathways in the coming months and years.
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